CIK 1582844
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 79.55% | 24 |
| Unclassified | 20.45% | 2 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | PRAX | Praxis Precision Medicines, Inc. | Health Care | 19.46% |
| 2 | TERNS PHARMACEUTICALS INC | Unclassified | 18.59% | |
| 3 | WHWK | Whitehawk Therapeutics, Inc. | Health Care | 8.37% |
| 4 | TNGX | Tango Therapeutics, Inc. | Health Care | 6.57% |
| 5 | DRUG | BRIGHT MINDS BIOSCIENCES INC. | Health Care | 5.81% |
| 6 | STRO | SUTRO BIOPHARMA, INC. | Health Care | 4.77% |
| 7 | ERAS | Erasca, Inc. | Health Care | 4.08% |
| 8 | SRZN | Surrozen, Inc./DE | Health Care | 3.58% |
| 9 | OCUL | OCULAR THERAPEUTIX, INC | Health Care | 3.57% |
| 10 | CMPX | Compass Therapeutics, Inc. | Health Care | 3.19% |
24/26 names classified · sector 79.5% of weight · industry 79.5% · mkt cap 71.3%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 79.5% of the book is sector-classified (unclassified names shown, never dropped).
Only 9% of book weight classified — the grid is NOT representative of the whole book.
Classified: 9.3% of book weight (2/26 names) · unclassified 90.7%: PRAX, , TNGX, DRUG, STRO, ERAS, SRZN, OCUL, CMPX, NERV +14 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | PRAXPRAXIS PRECISION MEDICINES I | 84,901 | $27M | 19.5% | ADD 2% |
| 2 | TERNS PHARMACEUTICALS INC | 495,772 | $26M | 18.6% | TRIM −22% |
| 3 | WHWKWHITEHAWK THERAPEUTICS INC | 3,410,402 | $12M | 8.4% | HOLD |
| 4 | TNGXTANGO THERAPEUTICS INC | 441,831 | $9M | 6.6% | ADD 56% |
| 5 | DRUGBRIGHT MINDS BIOSCIENCES INC | 111,996 | $8M | 5.8% | ADD 33% |
| 6 | STROSUTRO BIOPHARMA INC | 269,425 | $7M | 4.8% | ADD 299% |
| 7 | ERASERASCA INC | 354,575 | $6M | 4.1% | NEW |
| 8 | SRZNSURROZEN INC | 172,847 | $5M | 3.6% | TRIM −3% |
| 9 | OCULOCULAR THERAPEUTIX INC | 592,108 | $5M | 3.6% | TRIM −44% |
| 10 | CMPXCOMPASS THERAPEUTICS INC | 849,076 | $4M | 3.2% | TRIM −22% |
| 11 | NERVMINERVA NEUROSCIENCES INC | 709,500 | $4M | 3.0% | HOLD |
| 12 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 191,760 | $4M | 2.5% | ADD 223% |
| 13 | ARGXARGENX SE | 4,690 | $3M | 2.4% | TRIM −3% |
| 14 | OCSOCULIS HOLDING AG | 98,339 | $3M | 1.9% | TRIM −3% |
| 15 | RVMDREVOLUTION MEDICINES INC | 26,069 | $3M | 1.8% | ADD 210% |
| 16 | FDMT4D MOLECULAR THERAPEUTICS INC | 242,255 | $2M | 1.6% | NEW |
| 17 | AMLXAMYLYX PHARMACEUTICALS INC | 151,067 | $2M | 1.5% | TRIM −55% |
| 18 | TSHATAYSHA GENE THERAPIES INC | 439,464 | $2M | 1.4% | TRIM −3% |
| 19 | IDYAIDEAYA BIOSCIENCES INC | 48,234 | $2M | 1.1% | NEW |
| 20 | DSGNDESIGN THERAPEUTICS INC | 145,900 | $2M | 1.1% | TRIM −3% |
| 21 | UTHRUnited Therapeutics Corp. | 2,224 | $1M | 0.9% | TRIM −3% |
| 22 | TRDAENTRADA THERAPEUTICS INC | 89,358 | $1M | 0.8% | NEW |
| 23 | AVTXAVALO THERAPEUTICS INC | 60,808 | $907,863 | 0.6% | NEW |
| 24 | LBRXLB PHARMACEUTICALS INC | 28,919 | $713,143 | 0.5% | TRIM −4% |
| 25 | MAZEMAZE THERAPEUTICS INC | 19,335 | $577,150 | 0.4% | TRIM −3% |
| 26 | UNCYUNICYCIVE THERAPEUTICS INC | 57,959 | $381,370 | 0.3% | TRIM −3% |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| PRAXPRAXIS PRECISION MEDICINES I | 68K | 87K | 74K | 50K | 83K | 85K | $27M |
| TERNS PHARMACEUTICALS INC | 448K | 326K | 464K | 503K | 637K | 496K | $26M |
| WHWKWHITEHAWK THERAPEUTICS INC | 1.8M | 3.4M | 3.4M | 3.4M | 3.4M | 3.4M | $12M |
| TNGXTANGO THERAPEUTICS INC | — | — | — | — | 283K | 442K | $9M |
| DRUGBRIGHT MINDS BIOSCIENCES INC | 69K | 60K | 48K | 85K | 84K | 112K | $8M |
| STROSUTRO BIOPHARMA INC | — | — | — | — | 67K | 269K | $7M |
| ERASERASCA INC | — | — | — | — | — | 355K | $6M |
| SRZNSURROZEN INC | — | 170K | 170K | 178K | 178K | 173K | $5M |
| OCULOCULAR THERAPEUTIX INC | 1.1M | 1.2M | 1.0M | 1.2M | 1.1M | 592K | $5M |
| CMPXCOMPASS THERAPEUTICS INC | — | — | — | 840K | 1.1M | 849K | $4M |
| NERVMINERVA NEUROSCIENCES INC | — | — | — | — | 710K | 710K | $4M |
| MLTXMOONLAKE IMMUNOTHERAPEUTICS | — | — | — | — | 59K | 192K | $4M |
| ARGXARGENX SE | 7K | 7K | 7K | 6K | 5K | 5K | $3M |
| OCSOCULIS HOLDING AG | — | 125K | 107K | 102K | 102K | 98K | $3M |
| RVMDREVOLUTION MEDICINES INC | 112K | 67K | 56K | 8K | 8K | 26K | $3M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
